Osteoporotic fracture risk 'lower with NOACs than warfarin'

Observational study from Hong Kong shows little to choose between three non-vitamin K oral anticoagulants

The risk for osteoporotic fractures among patients with atrial fibrillation is substantially lower with non-vitamin K oral anticoagulants (NOACs) than with warfarin, an observational study shows.

blue and white capsules - NOAC

Researchers from the UK and Hong Kong examined data from the Hong Kong Hospital Authority on more than 23,500 new users of anticoagulants, including 14% treated with apixaban, 29% treated with dabigatran, 16% treated with rivaroxaban and 41% treated with warfarin.